SCHEMBL8510037

SCHEMBL8510037

CCC(O)Cc1ccncc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
TRPA1 O75762 1/20 0.42
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
LOXL2 Q9Y4K0 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.38
CYP2D6 P10635 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
PDE4B Q07343 1/20 0.36
CYP19A1 P11511 2/20 0.36
CHRM1 P11229 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29913385 0.84 ESR1 (0.45) TRPA1SLC6A2SLC6A4LMNA
SCHEMBL8560038 0.83 CYP3A4 (0.48) CYP3A4CYP1A2CYP2C9CYP2C19TRPA1
SCHEMBL14764141 0.78 CYP3A4 (0.52) CYP3A4CYP1A2CYP2C9CYP2C19SLC6A2
SCHEMBL108351 0.77 TRPA1 (0.61) CYP1A2TRPA1SLC6A2SLC6A4SLC6A3
SCHEMBL2479860 0.77 TRPA1 (0.61) CYP1A2TRPA1SLC6A2SLC6A4SLC6A3
SCHEMBL2480531 0.77 TRPA1 (0.61) CYP1A2TRPA1SLC6A2SLC6A4SLC6A3
SCHEMBL18864372 0.77 CYP3A4 (0.45) CYP3A4CYP1A2CYP2C9CYP2C19TRPA1
SCHEMBL8513064 0.77 CYP3A4 (0.55) CYP3A4CYP1A2CYP2C9CYP2C19TRPA1
Water SCHEMBL27753630 0.77 ESR1 (0.37) TRPA1SLC6A2SLC6A4CYP2D6
SCHEMBL28196643 0.77 CYP3A4 (0.59) CYP3A4CYP1A2CYP2C9CYP2C19SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255094-B2 Pyrido[4,3-B]indoles and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2016-02-09 US disclosed
US-20130190328-A1 PYRIDO[4,3-B]INDOLES AND METHODS OF USE MEDIVATION TECHNOLOGIES, INC. (US) 2013-07-25 US disclosed
US-20120136008-A1 PYRIDO[4,3-B]INDOLES AND METHODS OF USE MEDIVATION TECHNOLOGIES, INC. 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130190328-A1 PYRIDO[4,3-B]INDOLES AND METHODS OF USE HTR3B, HTR4, HTR2C CYP3A4 565/4885CYP1A2 848/4885CYP2C9 1421/4885
US-20120136008-A1 PYRIDO[4,3-B]INDOLES AND METHODS OF USE HTR3B, HTR4, HTR2C CYP3A4 565/4885CYP1A2 848/4885CYP2C9 1421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.